Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Brandes Small Cap Value Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasizing the fund's lower relative valuation and durable cash flows."
In Q3 2025, the Brandes Small Cap Value Fund returned 11.16%, slightly underperforming its benchmarks (Russell 2000 Index at 12.39% and Russell 2000 Value Index at 12.60%), while remaining significantly ahead on a YTD basis (16.57% vs. 10.39% and 9.04%). Positive contributors included healthcare holdings like Elanco, Phibro, and Avadel, plus the M&A-fueled Hanesbrands. Detractors occurred mainly in industrials (Kennametal, Hurco, Orion) and consumer staples/discretionary (Edgewell, American Outdoor Brands). The investment committee utilized market weakness to add to existing positions and buy new entries including Prestige Consumer Healthcare, Globant, and Sonoco. Strategically, the fund maintains heavy overweights in industrials and healthcare while staying underweight in financials, IT, and real estate.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
Growth Outlook
Market outlook remains above average conviction: The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
Risk Appetite
Risk appetite posture is above average conviction: The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
Forward Guidance
Forward guidance signal: The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
Language Signal
Tone analysis indicates above average conviction language: The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Brandes Small Cap Value Fund rose 11.16% in Q3, continuing its strong YTD outperformance. The manager active-bought high-quality laggards on short-term price weakness, emphasiz...
